Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -312016.95% is 35332% below its 3-year average of -880.60%, near the low end of its 3-year range (-312016.95%–0.00%).
1291.62% below its 12-month average of -22421.19%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3880.65%.
OPERATING MARGIN
-312016.95%
OPERATING MARGIN AVG TTM
-22421.19%
OPERATING MARGIN AVG 3Y
-880.60%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1291.62%
CURRENT VS 3Y AVG
-35332.22%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 384 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aspire Biopharma Holdings, Inc.
Market Cap
$1.02M
Operating Margin
-312016.95%
TTM Avg
-22421.19%
3Y Avg
-880.60%
5Y Avg
0.00%
Market Cap
$1.11M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$888387.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-24.80%
Market Cap
$885939.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$878396.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$787624.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-935.37%
5Y Avg
-623.58%
Market Cap
$707297.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.36M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.49M
Operating Margin
-1250.11%
TTM Avg
-662.88%
3Y Avg
-389.78%
5Y Avg
-16081.34%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.02M | -312016.95% | -22421.19% | -880.60% | 0.00% |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | 0.00% | 0.00% | 0.00% | -24.80% |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bone Biologics Corporation (BBLG)vs › | $878396.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $787624.00 | 0.00% | 0.00% | -935.37% | -623.58% |
| CDT Equity Inc. (CDT)vs › | $707297.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -1250.11% | -662.88% | -389.78% | -16081.34% |
| Curis, Inc. (CRIS)vs › | $1.54M | -348.43% | -378.38% | -440.18% | -397.59% |
Gross Margin
-1.9%
Operating Margin
-312017.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -3880.65% |
| 2026-03-31 | -5805.98% |
| 2025-12-31 | -43403.52% |
| 2025-09-30 | -59015.82% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
